Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome
| Status: | Archived |
|---|---|
| Conditions: | Endocrine |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | October 2008 |
| End Date: | August 2010 |
Test the hypothesis that nebivolol treatment improves fibrinolytic balance and insulin
sensitivity compared to metoprolol treatment in individuals with metabolic syndrome.
1. Test the hypothesis that nebivolol treatment decreases PAI-1 antigen and activity and
improves fibrinolytic balance compared to metoprolol treatment in individuals with
metabolic syndrome.
2. Test the hypothesis that nebivolol treatment improves insulin sensitivity compared to
metoprolol treatment in individuals with metabolic syndrome.
We found this trial at
1
site
1211 Medical Center Dr
Nashville, Tennessee 37232
Nashville, Tennessee 37232
(615) 322-5000
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
Click here to add this to my saved trials
